Larvol Delta - A-Study-to-Evaluate-Efficacy-Safety-and-Tolerability-of-Remibrutinib-in-Adult-Participants-With-Severe-Chronic-Pruritus-of-Unknown-Origin-CPUO

Rhapsido (remibrutinib) - Novartis

http://clinicaltrials.gov/ct2/show/NCT07700056

Sep 10, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next